Abbreviated Name

GRAIL

Lead Investigator

Lin UW, Daniel W. — University of Washington

Coordinating Investigator

Zheng, Yingye — Fred Hutchinson Cancer Center

Involved Investigators

• Lin UW, Daniel W. — University of Washington
• Larson, Matthew — GRAIL, LLC
• Zheng, Yingye — Fred Hutchinson Cancer Center

Abstract

Canary Foundation has supported the Prostate Active Surveillance Study (PASS), collecting biologic samples as well as clinical information while tracking patients for ultimate disease progression and/or institution of active treatment. The research under this Agreement is for use of GRAIL’s urine cfDNA methylation technology to monitor cancer progression in biobanked urine from prostate cancer patients collected as part of Canary Prostate Active Surveillance Study (PASS) urine study. For each patient, urine samples will be shipped to GRAIL on dry ice.

Aims

No aims available.

Analytic Method

TBD

Publications

• No publications available at this time for this protocol.

Biomarkers

• No biomarkers available at this time for this protocol.

Data Collections

• No data collections available at this time for this protocol.

 Team Project

Protocol ID

549

Protocol Type

Collaboration

Fields of Research

• Other

Collaborative Group

Prostate and Urologic Cancers Research Group

Cancer Types

• Malignant neoplasm of prostate

Phased Status

1